Table 3 Characteristics of participants stratified by diagnosis of metabolic syndrome (MetS) according to fasting plasma glucose or HbA1c or both

51.5

51.4

59.5

53.0

48.2 ± 15.0^{*† ‡}

53.6 ± 12.2^*

56.1 ± 13.2^*

58.2 ± 12.1

22.6 ± 3.1^{*† ‡}

25.3 ± 3.1^*

25.4 ± 3.1^*

26.1 ± 3.4

79.8 ± 9.4^{*† ‡}

89.1 ± 8.0^*

89.3 ± 8.4^*

91.5 ± 8.7

120.0 (110.0-128.7)^{*† ‡}

130.0 (120.0-142.3)^*

131.0 (120.0-144.7)^*

136.0 (123.3-149.3)

79.3 (70.7-83.3)^{*† ‡}

85.0 (80.0-90.7)

86.0 (80.0-91.0)

86.7 (80.0-91.8)

4.9 (4.6-5.3)^{*† ‡}

5.9 (5.7-6.3)

5.0 (4.7-5.3)^*†

6.4 (5.9-7.5)

5.4 (5.1-5.6)^*‡

5.4 (5.2-5.5)^*

5.9 (5.8-6.1)^*†

6.2 (5.9-6.8)

4.7 (4.1-5.3)^*‡

4.9 (4.3-5.7)^*

5.0 (4.5-5.7)^*

5.3 (4.7-6.0)

1.1 (0.8-1.5)^{*† ‡}

2.0 (1.3-2.7)

1.8 (1.2-2.5)

1.9 (1.3-2.8)

2.8 (2.3-3.4)^{*† ‡}

3.0 (2.3-3.5)^*

3.1 (2.5-3.8)^†

3.3 (2.6-3.9)

1.4 (1.2-1.7)^{*† ‡}

1.2 (1.0-1.5)

1.2 (1.1-1.5)

1.2 (1.0-1.4)

286.0 (233.0-349.0)^{*† ‡}

336.5 (281.5-411.0)

318.0 (256.0-377.0))^*†

328.0 (267.0-393.0)

1.3 (0.9-1.8)^{*† ‡}

1.9 (1.4-2.9)^*

1.6 (1.2-2.2)^*

2.2 (1.5-3.5)

141.0 (130.0-153.0)^*†

145.0 (133.0-157.0)

142.0 (131.0-154.0)^*

146.0 (135.0-159.0)

47.3 (45.3-49.5)

47.5 (45.5-49.7)

47.3 (45.3-49.3)

47.8 (45.7-49.8)

17.0 (13.0-25.0)^{*† ‡}

21.0 (14.0-31.5)^*

21.0 (15.0-29.0)^*

23.0 (17.0-32.5)

76.7 (68.2-86.6)^*†

73.7 (65.0-82.8)

74.4 (66.2-83.3)

72.8 (63.4-82.2)

1.0 (0.0-2.0)^*‡

1.0 (1.0-3.0)^*

2.0 (1.0-3.0)

2.0 (1.0-4.0)

0.9 (0.9-1.0)^*‡

0.9 (0.9-1.0)^*

1.0 (0.9-1.0)^†

1.0 (0.9-1.0)

2.8 (2.5-3.1)^*‡

2.8 (2.5-3.1)^*

2.9 (2.6-3.3)^†

3.0 (2.6-3.3)

1.3 (1.1-1.6)

1.3 (1.1-1.7)

1.3 (1.0-1.6)

1.3 (1.1-1.6)

6.0 (5.0-7.1)^*‡

6.1 (5.1-7.3)^*

6.2 (5.3-7.5)^*

6.5 (5.6-7.7)